{"data":[{"accessionNo":"0001213900-26-089989","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Vivo Opportunity, LLC","reportingCik":null,"personType":"OO","sharesOwned":7207573,"percentOfClass":4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001213900-26-089989","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Vivo Opportunity Fund Holdings, L.P.","reportingCik":null,"personType":"PN","sharesOwned":7207573,"percentOfClass":4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001213900-26-089989","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Vivo Opportunity Cayman Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":549487,"percentOfClass":0.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001213900-26-089989","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Vivo Opportunity Cayman, LLC","reportingCik":null,"personType":"OO","sharesOwned":549487,"percentOfClass":0.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000093751-26-000440","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"COMPASS THERAPEUTICS INC","ticker":"CMPX","cusip":"20454B104","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":9953653,"percentOfClass":5.5,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-26-001388","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":7764842,"percentOfClass":4.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-26-001388","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":7764842,"percentOfClass":4.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-26-001388","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":7764842,"percentOfClass":4.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-26-001388","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":7170971,"percentOfClass":4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-26-001388","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":4142020,"percentOfClass":2.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-26-001388","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":4142020,"percentOfClass":2.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-26-001388","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3028951,"percentOfClass":1.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-26-001388","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":3028951,"percentOfClass":1.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-26-001388","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":476311,"percentOfClass":0.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-26-001388","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":"20454B104","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":476311,"percentOfClass":0.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001193125-26-051513","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Blackstone Inc.","reportingCik":null,"personType":"CO","sharesOwned":6126182,"percentOfClass":3.4,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001193125-26-051513","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Blackstone Alternative Asset Management Associates LLC","reportingCik":null,"personType":"OO","sharesOwned":6126182,"percentOfClass":3.4,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001193125-26-051513","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Blackstone Holdings II L.P.","reportingCik":null,"personType":"PN","sharesOwned":6126182,"percentOfClass":3.4,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001193125-26-051513","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Blackstone Holdings I/II GP L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":6126182,"percentOfClass":3.4,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001193125-26-051513","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Blackstone Group Management L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":6126182,"percentOfClass":3.4,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001193125-26-051513","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Stephen A. Schwarzman","reportingCik":null,"personType":"IN","sharesOwned":6126182,"percentOfClass":3.4,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001193125-26-051513","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Spruce Street Aggregator L.P.","reportingCik":null,"personType":"PN","sharesOwned":3678362,"percentOfClass":2.1,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001193125-26-051513","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Blackstone Annex Master Fund L.P.","reportingCik":null,"personType":"PN","sharesOwned":2447820,"percentOfClass":1.4,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0002012383-26-000660","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":9271644,"percentOfClass":5.2,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001214659-25-016681","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":17176510,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001214659-25-016688","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":17176510,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001214659-25-016681","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":17176510,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001214659-25-016688","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":17176510,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001214659-25-016681","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":10274944,"percentOfClass":5.98,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001214659-25-016688","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":10274944,"percentOfClass":5.98,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001213900-25-111134","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Vivo Opportunity Fund Holdings, L.P.","reportingCik":null,"personType":"PN","sharesOwned":8995979,"percentOfClass":5.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001213900-25-111134","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Vivo Opportunity, LLC","reportingCik":null,"personType":"OO","sharesOwned":8995979,"percentOfClass":5.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001214659-25-016681","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":5568566,"percentOfClass":3.24,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001214659-25-016688","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":5568566,"percentOfClass":3.24,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001214659-25-016688","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":999750,"percentOfClass":0.58,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001214659-25-016681","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":999750,"percentOfClass":0.58,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001213900-25-111134","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Vivo Opportunity Cayman Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":549487,"percentOfClass":0.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001213900-25-111134","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Vivo Opportunity Cayman, LLC","reportingCik":null,"personType":"OO","sharesOwned":549487,"percentOfClass":0.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001214659-25-016688","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":333250,"percentOfClass":0.19,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0001214659-25-016681","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":333250,"percentOfClass":0.19,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-25-002825","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-22","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":8750000,"percentOfClass":5.1,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-25-002825","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-22","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":8750000,"percentOfClass":5.1,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-25-002825","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-22","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":8750000,"percentOfClass":5.1,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-25-002825","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-22","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":8070444,"percentOfClass":4.7,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-25-002825","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-22","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":4673550,"percentOfClass":2.7,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-25-002825","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-22","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":4673550,"percentOfClass":2.7,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-25-002825","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-22","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3396894,"percentOfClass":2,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-25-002825","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-22","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":3396894,"percentOfClass":2,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-25-002825","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-22","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":542486,"percentOfClass":0.3,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"},{"accessionNo":"0000921895-25-002825","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001738021","issuerName":"Compass Therapeutics, Inc.","ticker":"CMPX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-22","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":542486,"percentOfClass":0.3,"filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx"}],"updatedAt":"2026-11-05T00:17:35.004Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/cmpx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}